Who are Sodium picosulphate/magnesium Citrate's main competitors?

Direct comparators (same drug class / molecular target / therapeutic area): Pico-Salax and Sodium phosphate enema.

How often does this brief refresh?

Every 30 minutes from primary sources (FDA, EMA, MHRA, PMDA, ClinicalTrials.gov, USPTO). Subscribe to the RSS feed below for push alerts.

How do I get this as a recurring report?

Subscribe to /feed/ci/sodium-picosulphate-magnesium-citrate.xml in any RSS reader (Feedly, Inoreader, NewsBlur). Every regulatory action, trial readout, or patent event lands in your feed automatically.

Last reviewed 2026-05-17 · How we verify

Sodium picosulphate/magnesium Citrate — Competitive Intelligence Brief

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Sodium picosulphate/magnesium Citrate (Sodium picosulphate/magnesium Citrate) competitive landscape: 1 comparator, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Osmotic laxative / bowel cleanser. Area: Gastroenterology.

marketed Osmotic laxative / bowel cleanser Gastroenterology Small molecule Live · refreshed every 30 min

Target snapshot

Sodium picosulphate/magnesium Citrate (Sodium picosulphate/magnesium Citrate) — Luigi Sacco University Hospital. Sodium picosulphate acts as an osmotic laxative that draws water into the colon, while magnesium citrate provides additional osmotic effect to promote bowel evacuation.

Comparator set (1 drugs)

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

Drug	Generic	Sponsor	Phase	Class	Target	Approval / PDUFA
Sodium picosulphate/magnesium Citrate TARGET	Sodium picosulphate/magnesium Citrate	Luigi Sacco University Hospital	marketed	Osmotic laxative / bowel cleanser
Pico-Salax and Sodium phosphate enema	Pico-Salax and Sodium phosphate enema	Queen's University	marketed	Osmotic laxative / bowel cleanser

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Osmotic laxative / bowel cleanser class)

Luigi Sacco University Hospital · 1 drug in this class
Queen's University · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). Sodium picosulphate/magnesium Citrate — Competitive Intelligence Brief. https://druglandscape.com/ci/sodium-picosulphate-magnesium-citrate. Accessed 2026-05-17.

Build your own brief

Pick any drug + add comparators:

https://druglandscape.com/ci/{slug} — auto-detected competitors
https://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3 — explicit comparators
Brand names auto-resolve: /ci/keytruda → 301 → /ci/pembrolizumab